news
Allergan and Pfizer terminate merger agreement
6 April 2016 | By Victoria White
The decision was driven by the actions announced by the US Department of Treasury, which the companies concluded qualified as an “Adverse Tax Law Change”...
List view / Grid view
Mergers & Acquisitions
article
Trends to transform healthcare in 2016
10 March 2016 | By Victoria White, European Pharmaceutical Review
In the latest issue of European Pharmaceutical Review, the Kaiser Associates European Healthcare team predict four trends to transform healthcare in 2016. We've created an infographic highlighting their key predictions...
news
Abbott to acquire diagnostics company Alere
1 February 2016 | By Victoria White
Abbott has announced that it is to acquire Alere, significantly advancing Abbott's global diagnostics presence and leadership.
news
Shire to acquire Baxalta in $32 billion deal
11 January 2016 | By Victoria White
The combination of Shire and Baxalta will create the number one rare diseases platform in revenue and pipeline depth...
news
AstraZeneca to acquire 55% stake in Acerta Pharma
Following the news earlier this week that AstraZeneca had been in acquisition talks with Acerta Pharma, AstraZeneca today announced that it is to invest in a majority equity stake in the company.
news
AstraZeneca confirms talks with Acerta Pharma to acquire the company for $5 billion
AstraZeneca today confirmed that it is in talks with Acerta Pharma to acquire the company in a potential deal worth $5 billion.
news
Sartorius Stedim Biotech acquires Cellca
Sartorius Stedim Biotech (SSB), a leading international supplier for the pharma and biotech industries, acquired Cellca GmbH based in Laupheim, Germany. Founded in 2005, the company with around 30 employees generated sales revenue of approximately 6 million euros in 2014.
news
AbbVie completes acquisition of Pharmacyclics
26 May 2015 | By Victoria White
AbbVie has completed the acquisition of Pharmacyclics, enhancing AbbVie's scientific and commercial presence in the haematological oncology market...
news
Sartorius Stedim Biotech acquires UK-based CRO, BioOutsource
Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industries, today acquired the Scottish company BioOutsource Ltd.
news
Abbott commences tender Offer and Consent Solicitation for CFR International SpA 5.125% Senior Notes due 2022
16 December 2014 | By Abbott
Abbott announced that its wholly-owned subsidiary, Abbott Laboratories (Chile) Holdco (Dos) SpA, a Chilean corporation ("ALH"), has commenced a tender offer (the "U.S. Notes Offer"), in which it is offering to purchase for cash any and all of the outstanding $300 million aggregate principal amount of 5.125% Senior Notes due…
news
Abbott completes acquisition of Veropharm
15 December 2014 | By Abbott
Abbott announced that it has acquired control of Veropharm, a leading Russian pharmaceutical manufacturer...
news
Pharmaceutical industry feeling force of tax inversion legislation, says GlobalData Analyst
24 October 2014 | By GlobalData
The recent termination of AbbVie’s deal to acquire Shire makes this pharmaceuticals’ first major casualty of new US tax inversion legislation, and has jolted the industry out of its reverie, according to an analyst with research and consulting firm GlobalData.
news
Abbott completes acquisition of CFR Pharmaceuticals
29 September 2014 | By Abbott
Abbott has acquired control of CFR Pharmaceuticals, more than doubling its Latin American branded generics pharmaceutical presence and further expanding the company's presence in fast-growing markets...
news
Expiration of the U.S. Tender Offer for CFR Pharmaceuticals S.A.
24 September 2014 | By Abbott
Abbott announced the expiration of the tender offer for the purchase from U.S. holders of the ordinary shares of CFR Pharmaceuticals S.A., a Chilean corporation...
news
Thermo Fisher Scientific to acquire Life Technologies Corporation
Thermo Fisher Scientific (NYSE: TMO), the world leader in serving science, and Life Technologies Corporation (NASDAQ: LIFE), a leading life sciences company, have signed a definitive agreement under which Thermo Fisher will acquire Life Technologies for $76.00 in cash per fully diluted common share, or approximately $13.6 billion, plus the…
